title: Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
abstract: Great uncertainty exists as to whether aging enhances the detrimental effects of tissue plasminogen activator (tPA) on vascular integrity of the ischemic brain. We hypothesized that tPA treatment would augment ischemic injury by causing increased blood-brain barrier (BBB) breakdown as determined by quantitative serial T(1) and T(2) magnetic resonance imaging (MRI), and the transfer constant for gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA) from blood to brain in aged (18 to 20 months) compared with young (3 to 4 months) Wistar rats after middle cerebral artery occlusion, mediated through the acute disassembly of claudin 5 and occludin. Increased T(2) values over the first hour of postreperfusion were independently augmented following treatment with tPA (P<0.001) and aging (P<0.01), supporting a synergistic effect of tPA on the aged ischemic brain. Blood-brain barrier permeability for Gd-DTPA (K(Gd)) was substantial following reperfusion in all animal groups and was exacerbated by tPA treatment in the elderly rat (P<0.001). The frequency of hematoma formation was proportionately increased in the elderly ischemic brain (P<0.05). Both tPA and age independently increased claudin 5 and occludin phosphorylation during ischemia. Early BBB permeability detected by quantitative MRI following ischemic stroke is enhanced by increased age and tPA and is related to claudin 5 and occludin phosphorylation.
authors: Department of Clinical Neurosciences, Experimental Imaging Centre and Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
authors: Jaspreet
authors: J
authors: Kaur
authors: Ursula I
authors: UI
authors: Tuor
authors: Zonghang
authors: Z
authors: Zhao
authors: Philip A
authors: PA
authors: Barber
references: Pharmacol Rev. 2005 Jun;57(2):173-85
references: 15914466
references: Int J Stroke. 2009 Jun;4(3):159-68
references: 19659815
references: J Cereb Blood Flow Metab. 2009 May;29(5):1048-58
references: 19319145
references: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000213
references: 19821269
references: Stroke. 2002 Jan;33(1):79-86
references: 11779893
references: J Cereb Blood Flow Metab. 2010 May;30(5):900-3
references: 20216551
references: Neurobiol Aging. 2006 Jan;27(1):98-104
references: 16298245
references: BMJ. 2011 Jan 19;342:d306; author reply d312
references: 21248009
references: Magn Reson Med. 1995 Dec;34(6):824-34
references: 8598809
references: Stroke. 1995 Dec;26(12):2219-21
references: 7491639
references: Cerebrovasc Dis. 2003;15(1-2):98-105
references: 12499718
references: Magn Reson Imaging. 1994;12(3):403-11
references: 8007769
references: Cerebrovasc Brain Metab Rev. 1994 Spring;6(1):47-96
references: 8186069
references: Stroke. 2001 Nov;32(11):2486-91
references: 11692005
references: Magn Reson Med. 2005 Oct;54(4):813-21
references: 16142715
references: Magn Reson Med. 2003 Aug;50(2):283-92
references: 12876704
references: Mech Ageing Dev. 2003 Feb;124(2):143-6
references: 12633933
references: Biochem Biophys Res Commun. 2005 Feb 25;327(4):1114-23
references: 15652512
references: Lancet. 2000 May 13;355(9216):1670-4
references: 10905241
references: Acta Neuropathol. 2002 Mar;103(3):237-42
references: 11907803
references: Stroke. 2005 Jun;36(6):1247-52
references: 15879323
references: Diabetes. 1998 Dec;47(12):1953-9
references: 9836530
references: J Cell Biol. 1998 Jun 29;141(7):1539-50
references: 9647647
references: J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):317-21
references: 12588915
references: J Neurochem. 2008 Sep;106(6):2395-409
references: 18647175
references: N Engl J Med. 1995 Dec 14;333(24):1581-7
references: 7477192
references: Thromb Haemost. 1981 Aug 28;46(2):561-5
references: 6795744
references: Stroke. 2002 Mar;33(3):831-6
references: 11872911
references: Stroke. 1998 Jan;29(1):144-51
references: 9445344
references: J Cereb Blood Flow Metab. 2002 May;22(5):559-68
references: 11973428
references: Stroke. 1996 Sep;27(9):1663-7; discussion 1668
references: 8784145
references: Neurology. 2001 Apr 24;56(8):1015-20
references: 11320171
references: Stroke. 2010 Aug;41(8):1833-5
references: 20576948
references: J Magn Reson Imaging. 1993 Sep-Oct;3(5):746-54
references: 8400561
references: J Cereb Blood Flow Metab. 2005 May;25(5):583-92
references: 15716859
references: Stroke. 2008 Feb;39(2):427-32
references: 18174480
references: Free Radic Biol Med. 2005 Jul 1;39(1):51-70
references: 15925278
references: J Cell Biol. 2003 May 12;161(3):653-60
references: 12743111
references: Stroke. 2007 Jan;38(1):75-9
references: 17122437
references: J Neurosurg. 2005 Oct;103(4):687-94
references: 16266051
references: J Biol Chem. 1951 Nov;193(1):265-75
references: 14907713